Asia-Pacific lymphedema treatment market is expected to gain significant growth in the forecast period of 2022 to 2029. Data Bridge Market Research analyses that the Asia-Pacific lymphedema treatment market is growing with a CAGR of 11.4% in the forecast period of 2022 to 2029 and is expected to reach USD 239.13 million by 2029 from 102.69 million in 2022. Rising healthcare expenditure and escalation in innovation and technologies are drivers which are expected to the growth of the market in the forecast period.

Lymphedema refers to swelling that generally occurs in upper and lower extremities. Sometimes both arms and both legs swell. Lymphedema is most commonly caused by the removal of or damage to lymph nodes as a part of cancer treatment. It results from a blockage in lymphatic system, which is part of immune system. Stems from a damaged lymphatic system, can lead to infections, disfigurement, debilitating pain and disability. There is no cure for lymphedema.–62b55b362ffceb0f8de300e6–62b55b6d7c2c0515850f3b54

Leave a Reply

Your email address will not be published.